Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy

Outcome after PSMA PET/CT based radiotherapy in patients with biochemical persistence or recurrence after radical prostatectomy

Abstract Background PSMA PET/CT visualises prostate cancer residual disease or recurrence at lower PSA levels compared to conventional imaging and results in a change of treatment in a remarkable high number of patients. Radiotherapy with dose escalation to the former prostate bed has been associate...

Full description

Bibliographic Details
Main Authors: Nina-Sophie Schmidt-Hegemann, Wolfgang Peter Fendler, Harun Ilhan, Annika Herlemann, Alexander Buchner, Christian Stief, Chukwuka Eze, Paul Rogowski, Minglun Li, Peter Bartenstein, Ute Ganswindt, Claus Belka
Format: Article
Language:English
Published: BMC 2018-03-01
Series:Radiation Oncology
Subjects:
Prostate cancer
PSMA PET/CT
Biochemical recurrence
Biochemical persistence
Radiotherapy
Online Access:http://link.springer.com/article/10.1186/s13014-018-0983-4

Internet

http://link.springer.com/article/10.1186/s13014-018-0983-4

Similar Items